|
|||
|
Home > News : News & Events | ||
|
|||
|
|
|
|
News & Events
POSITIVE RESULTS IN INFLAMMATORY EYE DISEASE TREATMENT
Xigen announces the online publication of successful Phase II results for its lead compound Brimapitide (XG-102) in the American Journal of Ophthalmology. - January 2017
